Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Titel:
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Auteur:
Rogé, Maximilien Pointreau, Yoann Sargos, Paul Meyer, Emmanuel Schick, Ulrike Hasbini, Ali Rio, Emmanuel Bera, Guillaume Ruffier, Amandine Quivrin, Magali Chasseray, Mathieu Latorzeff, Igor Martin, Etienne Guimas, Valentine Pommier, Pascal Leroy, Thomas Ronchin, Philippe Lepinoy, Alexis Grand, Audrey Cartier, Lysian Didas, Ossama Denis, Fabrice Libois, Vincent Blanc-Lapierre, Audrey Supiot, Stéphane